49 results
20-F
2015 FY
EX-4.8
ADAP
Adaptimmune Therapeutics Plc
13 Oct 15
Annual report (foreign)
12:00am
has no right under the Contracts (Rights of Third Parties) Act 1999 to enforce any terms of this lease.
10 Environmental Conditions
For the purposes … prior to this Lease otherwise than through the act or default of the Tenant or any party under their control (an ‘Environmental Condition
20-F
2015 FY
EX-4.10
ADAP
Adaptimmune Therapeutics Plc
13 Oct 15
Annual report (foreign)
12:00am
the Contracts (Rights of Third Parties) Act 1999 to enforce any terms of this lease.
10 Environmental Conditions
For the purposes of this clause the expression … than through the act or default of the Tenant or any party under their control (an ‘Environmental Condition’) the Tenant shall not:
10.1
20-F
2015 FY
EX-4.14
ADAP
Adaptimmune Therapeutics Plc
13 Oct 15
Annual report (foreign)
12:00am
“B” — Building Rules
“C” — Estoppel Certificate Form
“D” — Environmental Reports
“E” — Work Letter
“F” — Authorization For Automatic
Payments Form
“G … rules and regulations to promote energy efficiency, sustainability and environmental standards for the Property, as the same may be changed from time
20-F
2015 FY
EX-4.9
ADAP
Adaptimmune Therapeutics Plc
13 Oct 15
Annual report (foreign)
12:00am
no right under the Contracts (Rights of Third Parties) Act 1999 to enforce any terms of this lease.
10 Environmental Conditions
For the purposes … prior to this Lease otherwise than through the act or default of the Tenant or any party under their control (an ‘Environmental Condition’) the Tenant
20-F
EX-4.11
j4e h37gzqyh43e
13 Oct 15
Annual report (foreign)
12:00am
8-K
EX-14.1
b2zd4ulsm7wrs1rl2
24 Jul 17
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
12:00am
20-F
EX-4.15
vk8uj6
13 Oct 15
Annual report (foreign)
12:00am
S-3ASR
EX-1.2
cpk809dbm 3z0dq
10 Aug 20
Automatic shelf registration
5:01pm
D
rqmn6 uchxt
2 Oct 14
$103.81M in equity / Series A Preferred Shares, sold $103.81M, 22 investors
12:00am
8-K
EX-1.1
stthsrisf iytjkeza
2 Jun 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
4:49pm
8-K
EX-1.1
u4vco04uwx jna2
22 Jan 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
5:30pm